WHOOP Announces Scientific Advisory Council to Advance Its Mission to Unlock Human Performance – Yahoo Finance

Share Article

The WHOOP Scientific Advisory Council will include medical and wellness experts such as Dr. Andrew Huberman, PhD, to enhance research and product innovation for improved holistic health outcomes
BOSTON, October 24, 2022–(BUSINESS WIRE)–WHOOP, the human performance company, today announced the launch of the WHOOP Scientific Advisory Council to enhance health research, influence product and feature innovations, and contribute to the overall membership experience. The Scientific Advisory Council will also leverage their diverse expertise to develop new benefits for WHOOP Unite, a comprehensive solution dedicated to supporting organizations across a wide range of industries with coaching, insights, and health programs.
"Everything we do at WHOOP is rooted in science and we are thrilled to partner with leading researchers and physicians to advance the knowledge of our community," said Kristen Holmes, VP of Performance Science, WHOOP. "The Scientific Advisory Council will provide strategic input to help our team create better health and performance outcomes for everyday members and WHOOP Unite customers."
The WHOOP Scientific Advisory Council is comprised of medical doctors, wellness practitioners, and health-tech experts who have a passion for fostering human performance through technology. Their areas of focus with WHOOP include women’s health and female physiology, mental health and stress, sleep and circadian rhythm, behavioral science, functional medicine and nutrition, recovery, and cardiovascular health. In addition to influencing product and feature updates, the Scientific Advisory Council will utilize WHOOP as a data collection method in relevant studies and contribute content to support the brand’s in-app digital coaching platform.
"As a WHOOP member, I’ve experienced the health benefits of the technology firsthand. It is also clear based on quality research that WHOOP can improve our understanding of the human body, mental and physical health, and performance," said Dr. Andrew Huberman, PhD- a Neuroscience Professor and host of the Huberman Lab Podcast. I’m honored to join the Scientific Advisory Council and work with other leaders to further the WHOOP mission of unlocking human performance."
In addition to this initial group of experts, WHOOP will continue to add new members to the Scientific Advisory Council to expand the brand’s investment in health, wellness, and human performance.
Meet the WHOOP Scientific Advisory Council:
Dr. Andrew Huberman, PhD – Dr. Huberman, is a neuroscientist and tenured Professor in the Department of Neurobiology at the Stanford University School of Medicine. He has made numerous significant contributions to the fields of brain development, brain function and neural plasticity, which is the ability of our nervous system to rewire and learn new behaviors, skills and cognitive functioning.
Dr. Allison Brager, PhD – Dr. Brager is a neurobiologist with expertise in behavioral genetics, sleep, and biological rhythms for the United States Army as Deputy Chief Science Officer of the U.S. Army John F. Kennedy Special Warfare Center and School. She is passionate about discovering new factors that promote resiliency in extreme environments. Dr. Brager also serves on the NCAA task force for mental health and sleep, contributing to the first edition of the NCAA student-athlete mental health handbook
Dr. Jessica Shepherd, MD, MBA, FACOG – Dr. Shepherd is a renowned OB/GYN and women's health expert. She is the Chief Medical Officer for Verywell Health, the founder and CEO of Sanctum Med + Wellness, and affiliated with Baylor University Medical Center in Dallas, Texas. In her Dallas practice, she works with a team of therapists, yoga instructors, Ayurvedic wellness coaches, nutritionists, exercise specialists and other health professionals dedicated to women’s health.
Dr. Stacy Sims, MSC, PHD – Dr. Sims is a forward-thinking international exercise physiologist and nutrition scientist who aims to revolutionize exercise nutrition and performance for women, implementing practical, science-based routines and behaviors. She has directed research programs at Stanford, AUT University, and the University of Waikato, focusing on female athlete health and performance and pushing the dogma to improve research on all women.
Dr. Samer Hattar, PhD – Dr. Hattar is the Senior Investigator and Chief of the Section on Light and Circadian Rhythms at the National Institute of Mental Health. His research focuses on light effects on circadian rhythms, sleep, mood and learning. Dr. Hattar also examines how intrinsically photosensitive retinal ganglion cells (ipRGCs) detect light and send light information to the brain to regulate physiology and behavior.
Dr. Gina Merchant, PhD – Dr. Merchant is a behavioral scientist whose expertise is at the intersection of psychology, data science, and behavior change design. She has extensive experience with digital health design, remote monitoring, wearables, and health coaching. She has expertise in chronic disease prevention, cardio-metabolic health, and an array of research methodologies.
Dr. Hazel Wallace, MD – Dr. Wallace is a UK-based medical doctor, nutritionist, and qualified personal trainer with a focus on women’s health. Her work aims to bridge the gap between conventional medical advice and the latest thoughts and developments in nutrition and other areas of lifestyle.
WHOOP, the human performance company, offers a wearable health and fitness coach to help people achieve their goals. The WHOOP membership provides best-in-class wearable technology, actionable feedback, and recommendations across recovery, sleep, training, and health. WHOOP serves professional athletes, Fortune 500 CEOs, executives, fitness enthusiasts, military personnel, frontline workers, and anyone looking to improve their performance. WHOOP Unite is a comprehensive solution dedicated to supporting organizations across a wide range of industries with coaching, insights, and health programs. Studies show WHOOP can positively change behavior, increase sleep, and improve physiological biomarkers. Founded in 2012, WHOOP is based in Boston and has raised more than $400 million in venture capital. The latest round of financing made WHOOP the world's most valuable standalone wearables company. Visit whoop.com for more information and connect with WHOOP on Instagram, Twitter, Facebook, LinkedIn, and YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221024005304/en/
Contacts for Media Inquiries:
Alex Jacobs, WHOOP
[email protected]
[email protected]
(Bloomberg) — The make-or-break nature of biotech trading was on full display Monday as a pair of stocks charged in opposite directions following key clinical trial data.Most Read from BloombergRenters Hit Breaking Point in a Sudden Reversal for LandlordsChina Stocks Slide as Leadership Overhaul Disappoints TradersAdidas to End Kanye West Partnership After ControversiesKorean Air Plane Overruns Runway While Landing in PhilippinesDove, Other Unilever Dry Shampoos Recalled Over Cancer RiskTricida
A Wall Street Journal article helped propel stocks forward on Friday after the piece implied the rate-setters at the Fed might put the brakes on heavy rate rises from December onwards. On account of the surge, all three major indexes put in the best weekly performance since June with the Nasdaq’s 5.2% gain leading the charge followed by the respective 4.9% and 4.7% upticks of the Dow and the S&P 500. Investors will naturally be hoping the market’s latest move upwards has staying power as each pr
The company had hoped to translate positive late-stage study results into more money, which has dwindled since the FDA forced it to revamp its study two years ago.
A recent poll on prescription drug prices found that 83% of Americans view prescription drug prices as too expensive. In recent years, U.S. lawmakers and regulatory agencies have worked together to begin tackling the concerns of Americans about the cost of prescription drugs. When President Obama signed the Affordable Care Act into law in 2010, this opened up an avenue for the first biosimilar drug to ultimately be approved and launched in 2015.
In this article, we discuss the 10 best pharma stocks to buy now. If you want to see more stocks in this selection, check out the 5 Best Pharma Stocks To Buy Now. With a compound annual growth rate (CAGR) of 9.1%, the global pharmaceuticals industry is projected to expand to $1587.1 billion in 2022 from […]
A vaccine candidate from Vaxcyte appears to offer better protection against bacterial infections than the Prevnar franchise from Pfizer.
Dove, Suave and Bed Head are among the aerosol dry shampoos recalled after they were found to contain benzene, which can cause cancer.
The drugmaker will again face analysts on Tuesday amid cautious hope for its neurodegenerative disease drugs and an ongoing CEO search. Here's what to watch for.
Increasing expenses amid inflation is shrinking margins for the Zacks Medical-Hospital industry players. However, HCA Healthcare (HCA), Acadia Healthcare (ACHC), Universal Health (UHS) and Tenet Healthcare (THC) are poised to win big with recovering patient volumes.
The company reported Phase 3 trial results for veverimer, which failed to show the required efficacy.
L'Oreal SA has been sued by a Missouri woman who alleges she developed uterine cancer as a result of using the French cosmetic company's hair-straightening products. The lawsuit, filed Friday in federal court in Chicago, came days after a study from the U.S. National Institute of Environmental Health Safety (NIEHS) finding that hair-straightening products may significantly increase the risk of uterine cancer among frequent users. The plaintiff, Jennifer Mitchell, said she was diagnosed with uterine cancer in 2018, after using L'Oreal's products since about 2000, when she was 10.
Until December 7, you can sign up, switch, or drop a plan, with the new coverage beginning January 1.
Do you count your calories? In April, new legislation came into force requiring all large restaurants in England to confess to the calorific content of each of their dishes, publishing the number on the menu. Not everyone agreed with this directive, but the UK has an obesity crisis – surely calorie counts are key to combating it?
“Symptoms as recorded previously are changing with the evolving variants of the virus.”
The documentary The Human Trial follows the search for a cure for global diabetes epidemic, and why it’s taking so long.
About 1,000 students at a Virginia high school were out sick last week with flu-like symptoms after the school's homecoming event may have turned into a
When it comes to healthcare spending, 'consumers can only really choose between paying up or walking away,' one analyst told MarketWatch.
Three New Yorkers attempted to order cocaine from a drug delivery service but later died of a fentanyl overdose when their batch was laced with the deadly drug.
Merck & Co Inc (NYSE: MRK) highlighted findings from a Phase 3 trial of Prevymis (letermovir) compared to valganciclovir for cytomegalovirus (CMV) prophylaxis in high-risk kidney transplant recipients. At 52 weeks following the kidney transplant, Prevymis was effective and non-inferior to valganciclovir for preventing CMV disease (10.4% vs. 11.8%). Also Read: Centre Piece Of Merck's $11.5B Acceleron Buyout Aces Late-Stage Cardiovascular Trial. In a pre-specified safety analysis, Prevymis-treated
Five clinics are the first for the financial giant's Morgan Health subsidiary, as well as the first operated by a partnership of a Seattle healthcare startup and Central Ohio Primary Care Physicians Inc.


You might also like

Surviving 2nd wave of corona

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort